+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
MALE
ID07164443

Phase 3 Study of Pasritamig With or Without JNJ-87189401 Plus Best Supportive Care Versus Placebo in Men With Advanced Metastatic Castration-resistant Prostate Cancer

Led by Janssen Research & Development, LLC · Updated on 2026-11-03

1203

Participants Needed

176

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the overall survival of pasritamig JNJ-78278343, alone or combined with JNJ-87189401, compared to placebo in men with metastatic castration-resistant prostate cancer mCRPC, a cancer that has spread beyond the prostate and no longer responds to hormone therapies. This Phase 3 trial aims to assess these treatments alongside best supportive care BSC to improve outcomes in late-line mCRPC. Participants receive study treatments through intravenous infusions, including two step-up doses of pasritamig or placebo followed by the target dose. In Part 2, some participants also receive JNJ-87189401 with pasritamig. Treatments continue until disease progression, intolerable side effects, death, withdrawal, or study end. All participants may receive BSC, which includes palliative radiation, steroids, pain medications, bone agents, and related procedures as needed. During the study, participants are monitored for survival, disease progression, symptoms, pain, fatigue, and side effects for up to 2 years and 8 months. Assessments include clinical labs and quality-of-life questionnaires. Researchers track adverse events and laboratory abnormalities to evaluate safety. The study supports ongoing care while measuring the impact of these treatments in advanced prostate cancer.

CONDITIONS

Brief Title

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Research Team

S

Study Contact

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here